Skip to main content

Atlas Certification to Enable Development of MDx-related Software

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Atlas Biolabs today said that it has achieved DIN EN ISO 13485:2003 + AC:2009 standard, allowing the company to develop a software-based expert system for assessing chromosomal aberrations.

The system will complement Atlas' genotyping and molecular karyotyping services.

According to the company, the certification is a milestone for Atlas and compliance is necessary to develop and distribute software that falls within the scope of the European directive 98/79/EC for in vitro diagnostics.

"The new certificate gives the company a stronger position in molecular diagnostics and makes it an ideal partner for other companies that are looking to develop or have developed in vitro diagnostic tools," Atlas said in a statement.

The company had been certified according to DIN EN ISO 9001 since 2008.

Based in Berlin, Atlas provides genomics services, such as microarray-based genomic services, targeted sequence capture, and next-generation sequencing analysis.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.